MARKET

AIM

AIM

Aim Immunotech
AMEX
0.4101
+0.0001
+0.02%
After Hours: 0.4199 +0.0098 +2.39% 18:47 02/27 EST
OPEN
0.4170
PREV CLOSE
0.4100
HIGH
0.4170
LOW
0.4100
VOLUME
87.21K
TURNOVER
0
52 WEEK HIGH
0.7487
52 WEEK LOW
0.3790
MARKET CAP
20.03M
P/E (TTM)
-0.9559
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at AIM last week (0219-0223)?
Weekly Report · 1d ago
AIM ImmunoTech Secures $2.5 Million Funding and Debt Terms
TipRanks · 02/20 21:44
Weekly Report: what happened at AIM last week (0212-0216)?
Weekly Report · 02/19 10:33
Buy Rating Affirmed for AIM ImmunoTech Amidst Promising Trials and Product Pipeline Developments
TipRanks · 02/15 18:45
AIM ImmunoTech Announces First Subject Dosed In Phase 1b/2 Study Evaluating Ampligen In Combination With AstraZeneca's Imfinzi For Pancreatic Cancer
The DURIPANC Study is an investigator-initiated, open-label, single-center study of durvalumab and rintatolimod in patients with metastatic pancreatic ductal adenocarcinoma. The primary objective of the study is to determine the combination therapy's efficacy.
Benzinga · 02/14 13:56
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers BioSig Technologies (NASDAQ:BSGM) stock increased by 7.7% to $0.96 during Monday's after-market session. The company's Q3 earnings report came out today. Alzamend Neuro stock rose 6.56% and G1 Therapeutics stock fell 37.5% during the same period.
Benzinga · 02/12 21:30
Weekly Report: what happened at AIM last week (0205-0209)?
Weekly Report · 02/12 10:26
AIM ImmunoTech Touts Ampligen’s Post-COVID Study Success
TipRanks · 02/10 09:20
More
About AIM
AIM ImmunoTech Inc. is an immuno-pharmaceutical company. The Company is focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases, including COVID-19. The Company’s flagship products are Ampligen (rintatolimod), a drug of large macromolecular ribonucleic acid (RNA) molecules and Alferon N Injection (Interferon Alfa-N3). Ampligen is approved for commercial sale in the Argentine Republic for the treatment of severe chronic fatigue syndrome (CFS) and is an experimental drug in the United States undergoing clinical development for the treatment of certain cancers and ME/CFS. Alferon N Injection is the registered trademark for its injectable formulation of natural alpha interferon. Alferon N Injection is a natural-source, multi-species alpha interferon approved for sale in the United States and Argentina for the intralesional treatment of refractory or recurring external genital warts in patients 18 years of age or older.

Webull offers AIM ImmunoTech Inc stock information, including AMEX: AIM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AIM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AIM stock methods without spending real money on the virtual paper trading platform.